Figure 2
Box-feather plots showing median and quartile lymphoproliferation responses. The figures show stimulation indices of proliferation in response to PHA (A), TA-CIN (B), HPV-16L2 (C), GST-E6 (D), GST-E7 (E) and TA-GW (F) in the whole group (n=19), lesion responders (R; n=12) and lesion non-responders (NR; n=7) at baseline (week 0), after imiquimod (week 10) and after vaccination (week 20). P-values that are statistically significant for stimulation indices (SI) at week 20 compared with week 0 are shown. The Wilcoxon's signed-ranks test was used to determine the significance of within-group differences before and after treatment. A P-value of ⩽0.05 was considered significant.
